Anebulo begins phase 1 trial of IV cannabis toxicity treatment

Investing.comThursday, September 25, 2025 at 11:34:28 AM
Anebulo begins phase 1 trial of IV cannabis toxicity treatment
Anebulo has initiated a phase 1 trial for its innovative intravenous cannabis toxicity treatment, marking a significant step in addressing cannabis-related health issues. This trial is crucial as it explores a new therapeutic avenue that could potentially improve patient outcomes and safety in cannabis use, reflecting the growing interest in medical cannabis solutions.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Acadia Pharmaceuticals stock price target maintained by BMO after trial miss
NegativeFinancial Markets
Acadia Pharmaceuticals faced a setback as BMO maintained its stock price target following a disappointing trial outcome. This news is significant for investors as it reflects ongoing challenges for the company in achieving its developmental goals, potentially impacting its market performance and investor confidence.
Soleno Therapeutics stock gains as competitor exits PWS treatment race
PositiveFinancial Markets
Soleno Therapeutics has seen a significant boost in its stock value following the news that a major competitor has exited the race for treatment of Prader-Willi Syndrome (PWS). This development is crucial as it not only strengthens Soleno's position in the market but also highlights the potential for their treatment to become a leading option for patients. Investors are optimistic about the future, as the reduced competition could lead to increased market share and revenue for Soleno.
Acadia stock falls after Phase 3 PWS trial fails to meet primary endpoint
NegativeFinancial Markets
Acadia Pharmaceuticals faced a setback as its stock dropped following the failure of its Phase 3 trial for PWS, which did not meet its primary endpoint. This news is significant as it raises concerns about the company's future prospects and the effectiveness of its treatment, impacting investor confidence and potentially delaying advancements in therapies for Prader-Willi Syndrome.
H.C. Wainwright reiterates Buy rating on Alector stock ahead of key trial
PositiveFinancial Markets
H.C. Wainwright has reaffirmed its Buy rating on Alector's stock as the company approaches a significant trial. This endorsement highlights the firm's confidence in Alector's potential to deliver promising results, which could positively impact its market position and investor interest. As the trial date nears, stakeholders are keenly watching how Alector's developments unfold, making this a crucial moment for the biotech firm.
Amazon trial begins on FTC claims it duped Prime subscribers
NegativeFinancial Markets
The trial against Amazon has commenced, with the Federal Trade Commission (FTC) alleging that the company misled its Prime subscribers. This case is significant as it raises questions about consumer rights and corporate transparency, potentially impacting millions of users who rely on Amazon's services. The outcome could set a precedent for how subscription services operate and how they communicate with their customers.
Analysis-From crisis to cannabis: Sri Lanka’s president surprises with pro-market pivot
PositiveFinancial Markets
Sri Lanka's president has made a surprising shift towards a pro-market approach by endorsing the cannabis industry, a move that could help revitalize the country's economy after recent crises. This pivot not only signals a change in policy but also opens up new opportunities for farmers and investors alike, potentially transforming Sri Lanka into a key player in the global cannabis market.
Google faces antitrust déjà vu as US seeks to break up its digital advertising business
NegativeFinancial Markets
Google is once again in the spotlight as the U.S. government seeks to break up its digital advertising business, citing abusive practices. This trial is significant because it could reshape the landscape of online advertising and challenge the dominance of major tech companies, potentially leading to more competition and better options for consumers.
Latest from Financial Markets
If you can’t work out why you’re struggling when the economy is doing OK, it’s because you’re on the losing side
NegativeFinancial Markets
A recent report from Oxford Economics highlights the struggles faced by younger and lower-income households despite an overall stable economy. Factors like tariffs, changing labor dynamics, and shifts in policy have disproportionately affected these groups, leading to financial difficulties. This matters because it sheds light on the hidden economic disparities that persist even in seemingly good times, urging policymakers to address these inequalities.
Lululemon downgraded amid US weakness and tougher competition
NegativeFinancial Markets
Lululemon has been downgraded due to concerns over weak performance in the US market and increasing competition. This is significant as it highlights the challenges the brand faces in maintaining its growth and market position, especially with rivals stepping up their game. Investors and consumers alike will be watching closely to see how Lululemon adapts to these pressures.
KB Home stock price target raised to $59 from $58 at RBC Capital
PositiveFinancial Markets
KB Home's stock price target has been raised to $59 from $58 by RBC Capital, indicating a positive outlook for the company's performance. This adjustment reflects confidence in KB Home's growth potential and could attract more investors, highlighting the company's resilience in the housing market.
Goldman Sachs downgrades copper supply forecast after Grasberg mine disruption
NegativeFinancial Markets
Goldman Sachs has downgraded its copper supply forecast due to recent disruptions at the Grasberg mine, one of the world's largest copper producers. This downgrade is significant as it highlights potential challenges in the copper market, which could lead to increased prices and impact various industries reliant on this essential metal. Investors and manufacturers alike should pay attention to these developments, as they may affect supply chains and production costs.
Demand for UK government debt falls; Jaguar Land Rover and Co-op count cost of cyber-attacks – business live
NegativeFinancial Markets
The Co-op Group has revealed that a recent cyber-attack could lead to a staggering £120 million loss in profits for the year, highlighting the severe impact of such incidents on businesses. This situation is compounded by the UK government's call to support Jaguar Land Rover's suppliers during their operational shutdown. The financial repercussions of these cyber threats not only affect the companies directly involved but also raise concerns about the broader implications for the economy and the need for enhanced cybersecurity measures.
Kroger urgently recalls food sold in thousands of stores in 31 states
NegativeFinancial Markets
Kroger has issued an urgent recall of food products sold across thousands of stores in 31 states, raising concerns about consumer safety. This recall affects several major grocery chains under Kroger's umbrella, including Pay Less Supermarkets and Ralphs. It's crucial for shoppers to stay informed and check their purchases to avoid potential health risks.